@ZacksSmallCap

Zacks Small Cap Research provides equity research on #smallcap and #microcap firms. https://xitter.cf/t.co/W18in20Snh

 Chicago IL
scr.zacks.com/
Joined October 2010
  • Tweets16.1K
  • Following176
  • Followers5.4K
12.8KMedia
$APVO: Mipletamig Combination Therapy Leads to 21% Stem Cell Transplantation Rate buff.ly/q14Crbt by @DavidBautz
$YOUL: Youlife Group Reports Strong 1st Half 2026 Results buff.ly/bxo4vx7
140
$HOVR: Advancing the Cavorite X7 Despite eVTOL Industry Turbulence #HybridFlight #AerospaceFuture #HorizonAircraftStock buff.ly/u7Gx7RZ
137
$NNUP: Building a Platform in Specialty Materials. Initiating Coverage of @NNUP_IR with a Valuation Target of $2.50. buff.ly/b20U3aE
261
$ICU: We forecast @SeaStarMedical revenue growing from about $2M in 2026 to $16M in 2028. The catalysts behind that path: buff.ly/KRAlpD3 #MedTech #SmallCaps

SeaStar Medical (ICU): New Survival Data and the Road to Adult Indications

SeaStar Medical (NASDAQ: ICU) presented new QUELIMMUNE data at ASN ...

youtube.com
1
333
Read the full analysis: buff.ly/HfgzeyS

ICU: QUELIMMUNE® Demonstrates Statistically Significant Survival Benefit in SAVE Registry Patients

By David Bautz, PhD NASDAQ: ICU READ THE FULL ICU RESEARCH REPORT Business Update Statistically Significant Survival Benefit Shown for QUELIMMUNE® On October 22, 2026, SeaStar Medical Holding Corp....

scr.zacks.com
80
$ICU @SeaStarMedical QUELIMMUNE® Demonstrates Statistically Significant Survival Benefit in SAVE Registry Patients buff.ly/HfgzeyS by @DavidBautz
294
$SNES @SenesTech Positive Takeaways of Virtual Meeting & of Longtime Institutional Shareholder Increased Stake buff.ly/V7hJsAR
1
300
$TRX $TRX.TO: @TRXGoldCorp Record Q4 Caps Fiscal 2026 at Top of Guidance; Drilling Ramp-Up Sets Stage for Expansion buff.ly/XXvHqHn
1
2
307
Investors are not Giving $COSM Credit for Growth #GlobalHealthcare #GlobalHealthcare #DigitalHealth buff.ly/SiKb9Kn
2
372
$YOUL: First-half revenue topped RMB1.9B, up 100%+ YoY, per the company. Youlife Group CSO Stanley Yang breaks down what drove it and the organic growth outlook from here: buff.ly/a2vfsnp #ChinaStocks #SmallCaps #Staffing

Executive Chat: Youlife Group (NASDAQ: YOUL) CSO Stanley Yang on...

Youlife Group (NASDAQ: YOUL) Chief Strategy Officer Stanley Yang ta...

youtube.com
1
336
Read the full transcript: buff.ly/UP1CDNw

Interview with Stanley Yang, Chief Strategy Officer of Youlife Group

scr.zacks.com
69
Zacks SCR retweeted
Zacks SCR@ZacksSmallCapOct 13
No Botox biosimilar has been approved since Botox launched in 1989. $AEON is developing ABP-450 to change that, with FDA studies expected in 2027. Our take in 60 seconds: buff.ly/qqOtKt5 #biotech #smallcapstocks #biosimilars
1
2
767
$ATNM: @ActiniumPharma Introduction to Radiopharmaceuticals buff.ly/0g3NHoE by @vanjohn10
321
Investors are not Giving $COSM Credit for Growth #GlobalHealthcare #GlobalHealthcare #DigitalHealth buff.ly/SiKb9Kn
1
1
332
$AEON: The Botox Files - A Biosimilar in the Making #DrugDevelopment #BiotechInnovation #TherapeuticNeurotoxins buff.ly/u6JDUgM
305
Get updates on small caps like $POET, $HOVR, and $GRRR directly to your inbox. Subscribe to Zacks SCR’s complimentary daily, weekly, or new coverage alerts: buff.ly/HOqY3DL #SmallCaps #MicroCaps #EquityResearch #Investing
465
$MRDN Growth examples include recent acquisition of Fairbet in Malta & sponsorship and also Expanse Studios’ strategic distribution agreement in Serbia #AI #igaming #softwaresolutions #technology buff.ly/wUk4bjd
252
$IXRRF: @IONIC_RE Improves Liquidity Position After Recent Capital Raise buff.ly/rL16bPn
1
1
9
486
$ARWR: @ArrowheadPharma Interim ARO-MAPT Data Shows Potential for TRiM™ Platform in CNS Diseases buff.ly/BUqS7mb by @DavidBautz
3
519
Load more